PTH and secondary hyperparathyroidism: To further investigate the in vivo inhibitory effect of the optogenetic approach on the elevated release of PTH, we established a rat model of secondary hyperparathyroidism (SHPT) (Fig. 5a–c and Supplementary Fig. 8a).